Levonorgestrel intrauterine system superior for controlling menorrhagia

At present, the levonorgestrel-IUS is approved for the indication of heavy menstrual bleeding in the United States only among women who first choose to use it as a contraceptive method, said Dr. Eve Espey.

Dr. Eve Espey

"The data from the study by Gupta et al support broadening its approval to include menorrhagia more generally, whether or not contraception is needed," she said.

Dr. Espey is with the department of obstetrics and gynecology at the University of New Mexico, Albuquerque. She reported no financial conflicts of interest. These remarks were taken from her editorial accompanying Dr. Gupta’s report (N. Engl. J. Med. 2013 Jan. 10 [doi:10.1056/NEJMe1214191]).